34 pubertal children with constitutional growth delay (CGD) were treated with clonidine orally twice a day. In 25 of the children the height velocity rose on clonidine treatment, and in 21 of them by more than 2 cm/yr during the first 6 months of treatment (mean [SD] growth increment 4.4 [0.5] cm/yr). Of the 22 who were treated for 12 months the increment in height velocity was maintained in 13 (3.4[0.4] cm/yr). Withdrawal of clonidine for 6 months did not stop the stimulatory effect of the drug on linear growth in 6 children, but in the other 8 children height velocities fell to pretreatment levels or below. In a few children reinstitution of clonidine for 2-4 months resulted in a new increment in height velocity. A high height standard deviation score and low growth velocity before treatment were predictive of a good growth response to clonidine. Clonidine did not induce noticeable side-effects. It may be a useful form of therapy for children with CGD.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0140-6736(87)92684-5DOI Listing

Publication Analysis

Top Keywords

height velocity
12
clonidine treatment
8
children height
8
months increment
8
increment height
8
clonidine
7
children
6
growth
5
height
5
treatment short
4

Similar Publications

Autoimmune hypothyroidism is categorized into Hashimoto thyroiditis (HT) and atrophic thyroiditis (AT). Although a consensus exists among Japanese endocrinologists that pediatric AT is associated with severe hypothyroidism, the question remains whether AT and HT are separate conditions. To investigate the clinical characteristics of pediatric AT, we conducted a comprehensive literature review using PubMed and ICHUSHI, a local database.

View Article and Find Full Text PDF

Cardiac adaptations in young triathletes: a 9-month longitudinal study during the peak height velocity period.

Eur J Appl Physiol

January 2025

Laboratoire de Pharm-Ecologie Cardiovasculaire (EA 4278), Université d'Avignon, 33 Rue Louis Pasteur, 84000, Avignon, France.

Purpose: The present study examined the influence of endurance training on the morphological and functional heart adaptations in young athletes throughout a longitudinal 9-month follow-up period during the adolescent peak height velocity (PHV).

Methods: Thirty-six 13- to 15-year-old males (twenty-three triathletes and thirteen untrained peers) were evaluated before and after a 9-month period during PHV. Maximal oxygen uptake ( ) and power at were assessed during incremental cycling test.

View Article and Find Full Text PDF

The countermovement jump (CMJ) is a widely used test to assess lower body neuromuscular performance. This study aims to analyze the validity and reliability of an iOS application using artificial intelligence to measure CMJ height, force, velocity, and power in unloaded and loaded conditions. Twelve physically active participants performed 12 CMJs with external loads ranging from 0% to 70% of their body mass while being simultaneously monitored with a pair of force platforms and the My Jump Lab application.

View Article and Find Full Text PDF

Vertical Jump Height Estimation Using Low-Sampling IMU in Countermovement Jumps: A Feasible Alternative to Motion Capture and Force Platforms.

Sensors (Basel)

December 2024

Department of Electronics, Information and Bioengineering (DEIB), Politecnico di Milano, 20133 Milano, Italy.

Vertical jump height from a countermovement jump is a widespread metric to assess the lower limb functionality. Motion capture systems and force platforms are considered gold standards to estimate vertical jump height; however, their use in ecological settings is limited. This study aimed to evaluate the feasibility of low-sampling-rate inertial measurement units as an alternative to the gold standard systems.

View Article and Find Full Text PDF

Unlabelled: Intake of New Zealand blackcurrant (NZBC) extract for 7 days has been shown to improve high-intensity intermittent running (HIIR) performance.

Objectives: We examined the repeat response of NZBC extract on HIIR performance.

Methods: Sixteen active males (age: 23 ± 3 yrs, height: 179 ± 5 cm, mass: 79 ± 11 kg, V˙O: 55.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!